<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>HIV in Primary Care ‚Äî Rapid Algorithm (NICE CKS 2025)</title>
  <meta name="description" content="One‚Äëpage clinical algorithm for HIV in primary care (NICE CKS 2025) ‚Äî fast memory aide and decision support." />
  <style>
    :root{
      --bg: #0b1020;
      --card: #0f172a;
      --muted: #94a3b8;
      --text: #e6eefc;
      --accent: #4f46e5;
      --accent-2: #22d3ee;
      --ok: #10b981;
      --warn: #f59e0b;
      --danger: #ef4444;
      --ring: 0 0 0 3px rgba(79,70,229,.25);
    }
    @media (prefers-color-scheme: light){
      :root{ --bg:#f8fafc; --card:#ffffff; --text:#0f172a; --muted:#475569; --accent:#4338ca; --accent-2:#0891b2; }
      .header .glass{ backdrop-filter:saturate(1.4) blur(8px); background:rgba(255,255,255,.6); }
    }
    *{ box-sizing:border-box }
    html,body{ height:100% }
    body{
      margin:0; background: radial-gradient(1200px 600px at 10% -10%, rgba(34,211,238,.2), transparent 60%),
                 radial-gradient(800px 500px at 110% 10%, rgba(79,70,229,.18), transparent 60%), var(--bg);
      color:var(--text); font:500 16px/1.55 ui-sans-serif, system-ui, -apple-system, Segoe UI, Roboto, Inter, "Helvetica Neue", Arial, "Apple Color Emoji", "Segoe UI Emoji";
    }
    .container{ max-width:1100px; margin:0 auto; padding:24px; }

    /* Header */
    .header{ position:sticky; top:0; z-index:20; border-bottom:1px solid rgba(148,163,184,.15); backdrop-filter:saturate(1.4) blur(8px); }
    .header .glass{ display:flex; align-items:center; gap:14px; padding:14px 24px; }
    .title{ font-size:clamp(20px, 2.2vw, 28px); font-weight:800; letter-spacing:.2px; }
    .badges{ display:flex; flex-wrap:wrap; gap:8px; margin-left:auto }
    .badge{ display:inline-flex; align-items:center; gap:8px; padding:6px 10px; border-radius:999px; background:linear-gradient(135deg, rgba(79,70,229,.16), rgba(34,211,238,.10)); border:1px solid rgba(148,163,184,.2); color:var(--text); font-size:12px; }
    .actions{ display:flex; gap:10px; margin-left:8px }
    .btn{ border:1px solid rgba(148,163,184,.25); background:linear-gradient(135deg,rgba(255,255,255,.06),rgba(255,255,255,.04)); color:var(--text); padding:8px 12px; border-radius:12px; font-weight:700; cursor:pointer; transition: all .2s ease; }
    .btn:hover{ transform: translateY(-1px); box-shadow: var(--ring); }

    /* Nav chips */
    .chips{ display:flex; flex-wrap:wrap; gap:8px; margin:14px 24px 0 24px; padding-bottom:12px; }
    .chip{ display:inline-flex; gap:10px; align-items:center; padding:8px 12px; border-radius:20px; background:rgba(148,163,184,.12); color:var(--text); text-decoration:none; border:1px solid rgba(148,163,184,.2); font-weight:600; }
    .chip:hover{ border-color: rgba(79,70,229,.55); }

    /* Layout */
    main{ padding-top:8px; }
    .grid{ display:grid; grid-template-columns:repeat(2, minmax(0,1fr)); gap:16px; }
    @media (max-width: 880px){ .grid{ grid-template-columns:1fr } }

    .card{ position:relative; background:linear-gradient(180deg, rgba(255,255,255,.05), rgba(17,24,39,.25)); border:1px solid rgba(148,163,184,.15); border-radius:18px; padding:18px 18px 16px; box-shadow: 0 10px 30px rgba(2,6,23,.15); }
    .card h2{ margin:0 0 8px 0; font-size: clamp(18px, 1.8vw, 22px); }
    .card .lead{ color:var(--muted); margin:0 0 8px 0; font-size:14px }
    .icon{ width:22px; height:22px; }
    .eyebrow{ display:flex; align-items:center; gap:10px; color:var(--muted); font-weight:700; text-transform:uppercase; letter-spacing:.12em; font-size:12px; margin-bottom:8px }

    ul{ margin:0; padding-left:18px; }
    li{ margin:6px 0 }

    .callout{ border-left:4px solid var(--accent-2); padding:10px 12px; background:rgba(34,211,238,.08); border-radius:12px; }
    .danger{ border-left-color: var(--danger); background: rgba(239,68,68,.08); }
    .warn{ border-left-color: var(--warn); background: rgba(245,158,11,.08); }
    .ok{ border-left-color: var(--ok); background: rgba(16,185,129,.08); }

    details{ border:1px dashed rgba(148,163,184,.35); border-radius:12px; padding:10px 12px; margin-top:10px }
    summary{ cursor:pointer; color:var(--accent-2); font-weight:700 }

    footer{ margin:26px 0 10px; color:var(--muted); font-size:12px }
    a{ color:var(--accent-2); text-underline-offset: 3px }

    /* Print styles ‚Äî compress to one A4 page if possible */
    @page{ size: A4 portrait; margin: 10mm }
    @media print{
      body{ background: white; }
      .header, .chips, .actions{ display:none !important }
      .container{ padding:0 }
      .card{ break-inside: avoid; border-color:#ddd; box-shadow:none; background:white }
      .grid{ grid-template-columns:1fr 1fr; gap:10px }
      .title{ font-size:18px }
      ul{ padding-left:16px }
    }
  </style>
</head>
<body>
  <header class="header">
    <div class="glass container">
      <div class="title">HIV in Primary Care ‚Äî Rapid Algorithm</div>
      <div class="badges">
        <span class="badge" title="National context">NICE CKS ‚Ä¢ UK NHS ‚Ä¢ Primary Care</span>
        <span class="badge" title="Revision date">Last revised: Mar¬†2025</span>
      </div>
      <div class="actions">
        <button class="btn" onclick="window.print()" aria-label="Print this page">üñ®Ô∏è¬†Print / Save PDF</button>
      </div>
    </div>
    <nav class="chips">
      <a class="chip" href="#test">When to test</a>
      <a class="chip" href="#initial">Initial actions</a>
      <a class="chip" href="#pep">Post‚Äëexposure prophylaxis (PEP)</a>
      <a class="chip" href="#mgmt">Management principles</a>
      <a class="chip" href="#refer">Refer urgently</a>
      <a class="chip" href="#support">Patient support</a>
      <a class="chip" href="#mnemonic">Mnemonic</a>
    </nav>
  </header>

  <main class="container">
    <section id="test" class="card">
      <div class="eyebrow">When to test for HIV</div>
      <h2>Offer an HIV test if any of the following apply</h2>
      <p class="lead">Aim for early diagnosis; don‚Äôt wait for advanced disease. Respect confidentiality and obtain informed consent.</p>
      <ul>
        <li><strong>Patient requests</strong> testing (no risk disclosure required).</li>
        <li><strong>Risk factors</strong> present (sexual, injecting, occupational, transfusion in high‚Äërisk settings, etc.).</li>
        <li><strong>Another STI</strong> is diagnosed.</li>
        <li><strong>AIDS‚Äëdefining</strong> illness, <strong>indicator condition</strong>, or <strong>clinical features</strong> suggest HIV.</li>
        <li><strong>New GP registration</strong> or having a blood test in an area of high prevalence (&gt;2/1000, age 15‚Äì59).</li>
        <li><strong>Pregnancy</strong> (routine antenatal screening).</li>
        <li><strong>Children at risk</strong> ‚Äî test with specialist paediatric input.</li>
      </ul>
      <div class="callout warn">
        If a venous sample is declined, offer a <em>mouth swab</em> or <em>finger‚Äëprick</em> alternative. If testing deferred, signpost to local services and self‚Äësampling kits (e.g., freetesting.hiv).
      </div>
      <details>
        <summary>Common indicator conditions (‚â•1/1000) ‚Äî tap to view</summary>
        <ul>
          <li>STIs; malignant lymphoma; anal/cervical dysplasia.</li>
          <li>Herpes zoster; hepatitis B/C; unexplained lymphadenopathy.</li>
          <li>Mononucleosis‚Äëlike illness; community‚Äëacquired pneumonia.</li>
          <li>Unexplained leukocytopenia or thrombocytopenia &gt;4 weeks.</li>
          <li>Seborrhoeic dermatitis/exanthema; severe/atypical psoriasis.</li>
          <li>Peripheral neuropathy; mononeuritis; subcortical dementia; MS‚Äëlike disease.</li>
          <li>Unexplained weight loss, fever, chronic diarrhoea, chronic renal impairment.</li>
          <li>Oral hairy leukoplakia; unexplained oral candidiasis.</li>
        </ul>
      </details>
    </section>

    <section id="initial" class="card">
      <div class="eyebrow">Initial actions in primary care</div>
      <h2>Assess, test, and plan next steps</h2>
      <ul>
        <li><strong>History:</strong> risks, symptoms (fever, weight loss, sweats, diarrhoea, rashes, oral candida, ulcers), past admissions.</li>
        <li><strong>Examination:</strong> maculopapular rash; extra‚Äëinguinal lymphadenopathy; oral candidiasis; look for PCP, TB, CMV retinitis, lymphoma, Kaposi‚Äôs.</li>
        <li><strong>Testing:</strong> arrange appropriate HIV test per local lab; discuss timing and <em>window period</em> (Ab usually 4‚Äì6 wks; up to 12 wks).</li>
        <li><strong>Pre‚Äëtest discussion:</strong> benefits, confidentiality, how results will be given, consent; consider referral to GUM if complex needs.</li>
        <li><strong>Results:</strong> if <em>negative</em>, consider repeat to cover window; if <em>positive</em>, lab will request confirmation ‚Äî give supportive messaging and <strong>refer urgently</strong> (see below) with follow‚Äëup in a few days.</li>
      </ul>
      <div class="callout danger"><strong>Admit</strong> for urgent specialist assessment if seriously unwell or concern for PCP, severe LRTI/TB, progressive neurological signs, visual symptoms (possible CMV retinitis), Kaposi‚Äôs (lung/gut), or serious ART adverse effects.</div>
    </section>

    <section id="pep" class="card">
      <div class="eyebrow">Post‚Äëexposure prophylaxis (PEP)</div>
      <h2>Exposure to HIV is a <em>medical emergency</em> ‚Äî act fast</h2>
      <div class="callout ok"><strong>Start as soon as possible</strong> (ideally within 24h; within 72h maximum) and arrange specialist follow‚Äëup & baseline tests (HIV, HBV, HCV).</div>
      <h3>Occupational exposure ‚Äî immediate first aid</h3>
      <ul>
        <li>Wash skin/wounds with soap & water; irrigate mucous membranes with water.</li>
        <li>Irrigate eyes with saline/water; remove contact lenses first.</li>
        <li>Encourage bleeding from puncture wounds; <em>do not suck</em>. Clean small wounds with antiseptic.</li>
        <li>Follow local 24/7 pathway (usually via A&amp;E) for urgent advice/PEP; report to HSE (RIDDOR) per policy.</li>
      </ul>
      <h3>Sexual exposure (PEPSE)</h3>
      <ul>
        <li>Consider PEP after condomless sex or condom failure with a person with HIV or high‚Äërisk status.</li>
        <li><strong>Usually not indicated</strong> if the HIV‚Äëpositive partner is adherent to ART with <em>confirmed</em> sustained undetectable viral load (&lt;200 copies/ml for &gt;6 months).</li>
        <li>Offer based on risk assessment (including sexual assault) and initiate promptly; arrange HIV testing at <strong>8‚Äì12 weeks</strong>.</li>
      </ul>
      <h3>Other exposures</h3>
      <ul>
        <li><strong>Community needlestick:</strong> PEP generally not recommended (very low risk); seek expert advice if unusual risk factors.</li>
        <li><strong>Human bites:</strong> PEP generally not recommended; risk is likely negligible (&lt;1 in 10,000). Expert advice if higher‚Äërisk scenario.</li>
      </ul>
    </section>

    <section id="mgmt" class="card">
      <div class="eyebrow">Established HIV ‚Äî primary care role</div>
      <h2>Management principles (specialist‚Äëled HIV care)</h2>
      <ul>
        <li><strong>Health promotion & immunisation:</strong> influenza, pneumococcal, hepatitis B; routine screening per guidelines.</li>
        <li><strong>Comorbidity care:</strong> low threshold to investigate <em>dyslipidaemia/insulin resistance</em> and CVD risk. <em>BHIVA (2024)</em>: offer statin for <strong>all ‚â•40 yrs</strong> for primary CVD prevention ‚Äî initiate & monitor in primary care.</li>
        <li><strong>Drug interactions:</strong> check BNF and the <a href="https://www.hiv-druginteractions.org" target="_blank" rel="noopener">HIV Drug Interactions</a> resource before prescribing.</li>
        <li><strong>Mental health:</strong> higher risk of depression, anxiety, PTSD, insomnia, substance use; some ART can affect mood/sleep. Consider specialist input.</li>
        <li><strong>Sexual & reproductive health:</strong> contraception, cervical screening (initial colposcopy after diagnosis; annual cytology thereafter under specialist care), fertility advice.</li>
        <li><strong>Visual symptoms:</strong> very low threshold for urgent ophthalmology/HIV specialist review (possible CMV retinitis).</li>
        <li><strong>Bone/renal health:</strong> consider ART effects and lifestyle factors; seek specialist advice as needed.</li>
        <li><strong>ART issues:</strong> assess adherence/side‚Äëeffects and liaise with the HIV team.</li>
      </ul>
    </section>

    <section id="refer" class="card">
      <div class="eyebrow">When to refer urgently</div>
      <h2>Same‚Äëday to 2‚Äëweek pathways depending on scenario</h2>
      <ul>
        <li><strong>All new positive HIV results</strong> ‚Äî urgent HIV clinic (preferably within 48h, at latest 2 weeks).</li>
        <li><strong>Acutely unwell</strong> or suspected serious infection: PCP, pneumonia, TB or atypical mycobacteria.</li>
        <li><strong>Visual symptoms</strong> suggestive of CMV retinitis (even mild floaters/reduced vision).</li>
        <li><strong>Neurological</strong> signs (confusion, headache, focal deficits) ‚Äî possible cryptococcal meningitis, cerebral toxoplasmosis, or lymphoma.</li>
        <li><strong>Kaposi‚Äôs</strong> involving lung or gut; severe systemic illness.</li>
        <li><strong>Severe or life‚Äëthreatening ART AEs:</strong> hypersensitivity, lactic acidosis, hepatotoxicity, marrow suppression, pancreatitis.</li>
        <li><strong>GI:</strong> oesophageal candidiasis; persistent diarrhoea; viral hepatitis coinfection.</li>
        <li><strong>Derm/oncology:</strong> suspected Kaposi‚Äôs sarcoma (urgent); atypical anogenital lesions (2‚Äëweek colorectal rule).</li>
        <li><strong>Oral/dental:</strong> severe/resistant oral candidiasis (HIV specialist); gingivitis/dental abscess (dentist).</li>
        <li><strong>Mental health/cognitive:</strong> complex psychiatric needs or HIV‚Äërelated cognitive impairment.</li>
      </ul>
    </section>

    <section id="support" class="card">
      <div class="eyebrow">Patient support & resources</div>
      <h2>Build trust, reduce stigma, and connect to help</h2>
      <ul>
        <li>Reinforce <strong>confidentiality</strong>, discuss disclosure and partner notification (specialist services can assist).</li>
        <li>Signpost reliable information & support: <a href="https://www.aidsmap.com" target="_blank" rel="noopener">NAM aidsmap</a>, <a href="https://www.tht.org.uk" target="_blank" rel="noopener">Terrence Higgins Trust</a>, local sexual health clinics.</li>
        <li>Arrange <strong>follow‚Äëup within a few days</strong> after diagnosis to address questions and wellbeing.</li>
      </ul>
    </section>

    <section id="mnemonic" class="card">
      <div class="eyebrow">Memory cue</div>
      <h2>TEST ‚Üí TREAT ‚Üí REFER ‚Üí SUPPORT</h2>
      <p class="lead">A four‚Äëstep mental model to keep consults safe and efficient.</p>
      <div class="callout">
        <strong>TEST</strong> when risks/indicators are present ¬∑ <strong>TREAT</strong> exposures quickly with PEP pathways ¬∑ <strong>REFER</strong> positive results & red flags ¬∑ <strong>SUPPORT</strong> with vaccines, comorbidity care, and psychosocial help.
      </div>
    </section>

    <footer>
      <p>Designed for single‚Äëpage reference during consultations. Print‚Äëfriendly (A4) with dark/light mode support. This summary is intended for clinicians and is based on current UK guidance (NICE CKS, BHIVA/BASHH) as of March¬†2025. Always follow local pathways and formularies.</p>
    </footer>
  </main>
</body>
</html>
